Correlation Between Erasca and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Erasca and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Erasca Inc and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Erasca and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Mineralys Therapeutics,.

Diversification Opportunities for Erasca and Mineralys Therapeutics,

-0.24

Correlation Coefficient

Erasca  Mineralys Therapeutics,

Very good diversification

The 3 months correlation between Erasca and Mineralys is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Erasca i.e., Erasca and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Erasca and Mineralys Therapeutics,

Given the investment horizon of 90 days Erasca Inc is expected to generate 1.97 times more return on investment than Mineralys Therapeutics,. However, Erasca is 1.97 times more volatile than Mineralys Therapeutics, Common. It trades about 0.06 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.04 per unit of risk. If you would invest  125.00  in Erasca Inc on May 6, 2025 and sell it today you would earn a total of  15.00  from holding Erasca Inc or generate 12.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Erasca Inc  vs.  Mineralys Therapeutics, Common

Erasca Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Erasca unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Erasca and Mineralys Therapeutics,

The main advantage of trading using opposite Erasca and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Erasca Inc and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.